KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Change in Cash (2016 - 2026)

West Pharmaceutical Services has reported Change in Cash over the past 18 years, most recently at -$269.9 million for Q1 2026.

  • Quarterly Change in Cash fell 235.7% to -$269.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $117.2 million through Mar 2026, up 159.31% year-over-year, with the annual reading at $306.7 million for FY2025, 183.05% up from the prior year.
  • Change in Cash was -$269.9 million for Q1 2026 at West Pharmaceutical Services, down from $162.8 million in the prior quarter.
  • Over five years, Change in Cash peaked at $165.3 million in Q4 2022 and troughed at -$269.9 million in Q1 2026.
  • The 5-year median for Change in Cash is -$6.3 million (2024), against an average of -$14.2 million.
  • Biggest five-year swings in Change in Cash: crashed 3051.25% in 2024 and later surged 2684.13% in 2025.
  • Tracing WST's Change in Cash over 5 years: stood at $165.3 million in 2022, then tumbled by 127.04% to -$44.7 million in 2023, then skyrocketed by 85.91% to -$6.3 million in 2024, then surged by 2684.13% to $162.8 million in 2025, then tumbled by 265.79% to -$269.9 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$269.9 million, $162.8 million, and $118.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.